Implementation of a conservative checklist-based protocol for oxytocin administration: maternal and newborn outcomes
Steven L. Clark(HCA Healthcare), Janet A. Meyers(HCA Healthcare), Darla D. Miller(HCA Healthcare), Donna Frye(HCA Healthcare), Gary Hankins, Michael A. Belfort(Society for Maternal-Fetal Medicine), George Saade
Cited by 158
Related Papers
First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: A population-based screening study (The FASTER Trial)
|American Journal of Obstetrics and Gynecology|2004|620
Maternal death in the 21st century: causes, prevention, and relationship to cesarean delivery
|American Journal of Obstetrics and Gynecology|2008|620
Center of excellence for placenta accreta
|American Journal of Obstetrics and Gynecology|2014|506
Placenta accreta
|American Journal of Obstetrics and Gynecology|2010|478
Maternal morbidity in patients with morbidly adherent placenta treated with and without a standardized multidisciplinary approach
|American Journal of Obstetrics and Gynecology|2014|476